750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物IDENTITY
COMPUTED
GHS
This chemical does not meet GHS hazard criteria for 35.2% (38 of 108) of reports.
Warning
H302+H312+H332 (21.3%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation];H302 (26.9%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (21.3%): Harmful in contact with skin [Warning Acute toxicity, dermal];H315 (59.3%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (59.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H332 (21.3%): Harmful if inhaled [Warning Acute toxicity, inhalation];H335 (58.3%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H413 (25.9%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 108 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 38 of 108 reports by companies.;There are 13 notifications provided by 70 of 108 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
HAZARDS
Acute Tox. 4 (26.9%);Acute Tox. 4 (21.3%);Skin Irrit. 2 (59.3%);Eye Irrit. 2 (59.3%);Acute Tox. 4 (21.3%);STOT SE 3 (58.3%);Aquatic Chronic 4 (25.9%)
ALIASES
REACTIONS
750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物750 AstraZeneca ELN dataset
750 AstraZeneca ELN dataset
查看条件与参与物